Back
ESC Professional Premium Access

Endothelial retargeting of AAV9 in vivo

Session: Metabolic syndrome and vascular dysfunction
Topic: Gene Therapy, Cell Therapy
Speaker: Doctor T. Bozoglu (Munich, DE)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Tarik Bozoglu

University Hospital rechts der Isar, Munich (Germany)
0 follower

5 more presentations in this session

Endothelial-specific deletion of methyltransferase Set7 protects mice from obesity-induced endothelial dysfunction

Speaker: Doctor J. Sanchez Ceinos (Stockholm, SE)

Access
Abstract
Slides
Like
Thumbnail

Targeting Neurofibromin 2 (NF2) Prevents Endothelial Dysfunction in Obesity: A Study in Mice and Humans

Speaker: Doctor S. Mohammed (Zurich, CH)

Access
Abstract
Slides
Like
Thumbnail

Adverse epigenetic signatures driven by histone methyltransferase EZH2 contribute to hyperglycaemia-induced endothelial dysfunction

Speaker: Doctor J. Sanchez Ceinos (Stockholm, SE)

Access
Abstract
Slides
Like
Thumbnail

Monocyte and endothelial dysfunction induced by hyperglycemia is reversed by Empagliflozin mainly through glucose-transport independent mechanisms

Speaker: Miss D. Semo (Munster, DE)

Access
Abstract
Slides
Like
Thumbnail

Impact of metabolic substrate modification on myocardial efficiency in a rat model of obesity and diabetes

Speaker: Miss J. Virta (Turku, FI)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Metabolic syndrome and vascular dysfunction

Speakers: Doctor T. Bozoglu, Doctor J. Sanchez Ceinos, Doctor S. Mohammed, Doctor J. Sanchez Ceinos, Miss D. Semo...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources